• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SUD
Click for more information
0.00% 4.2¢

SUDA PHARMACEUTICALS LTD

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SUD
Ann: Initial Director's Interest Notice 		28/03/19 2 279
28/03/19 Last post  Buckland Comments Created with Sketch.  2  Views Created with Sketch.  279 
SUD
I get the impression... 		28/03/19 23 2.6K
28/03/19 Last post  Buckland Comments Created with Sketch.  23  Views Created with Sketch.  2.6K 
SUD
Ann: SUDA Appoints David Simmonds To The Board 		28/03/19 7 1.5K
28/03/19 Last post  Buckland Comments Created with Sketch.  7  Views Created with Sketch.  1.5K 
SUD
Is Aytu BioScience (AYTU) Building Another Arbor Pharmaceuticals?. Investors Say Yes 		27/03/19 2 523
27/03/19 Last post  borisboy Comments Created with Sketch.  2  Views Created with Sketch.  523 
SUD
Global Anti-migraine Drugs Market US$ 9.5 Billion by 2025 		26/03/19 8 1.7K
26/03/19 Last post  Buckland Comments Created with Sketch.  8  Views Created with Sketch.  1.7K 
SUD
Strides / Artimist / TGA 		26/03/19 39 7.2K
26/03/19 Last post  troutfisho Comments Created with Sketch.  39  Views Created with Sketch.  7.2K 
SUD
Aytu BioScience Announces ZolpiMist Global Distribution Agreement with SUDA Pharmaceuticals
2
25/03/19 108 23K
25/03/19 Last post  Diesteach Comments Created with Sketch.  108  Views Created with Sketch.  23K 
SUD
Anagrelide 		24/03/19 3 852
24/03/19 Last post  Wasabibarako Comments Created with Sketch.  3  Views Created with Sketch.  852 

See All Discussions arrow Created with Sketch.

Top Stories

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.